Renaissance Technologies Portfolio holdings
Renaissance Technologies is a hedge fund firm that trades with computer models built on mathematics and statistics. It began in 1978 as Monemetrics, founded by Jim Simons, a mathematician and former Cold War codebreaker, and took its current name in 1982. The firm launched its Medallion Fund in 1988 and staffs its research with mathematicians, statisticians, physicists, astronomers and computer scientists. Medallion trades over short time spans across many asset types, and it has been closed to outside investors since 1993, open only to current and past employees and their families.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.15% |
| 2 | Technology | 16.1% |
| 3 | Financials | 11.82% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Humana
HUM
$49.5B
| $892M | 1.05% |
3,660,100
+929,000
| +34% | +$228M |
2015 Q2
9 quarters
|
|
2
Gilead Sciences
GILD
$213B
| $829M | 0.98% |
10,230,899
-176,949
| -2% | -$13.5M |
2014 Q4
11 quarters
|
|
3
Amgen
AMGN
$255B
| $730M | 0.86% |
3,917,700
+517,555
| +15% | +$91.7M |
2013 Q2
17 quarters
|
|
4
NVIDIA
NVDA
$5.02T
| $717M | 0.84% |
160,404,000
-29,947,720
| -16% | -$125M |
2013 Q4
15 quarters
|
|
5
NetEase
NTES
$72.5B
| $708M | 0.83% |
13,415,250
-214,750
| -2% | -$12.3M |
2013 Q2
17 quarters
|
|
6
Colgate-Palmolive
CL
$75.8B
| $700M | 0.82% |
9,604,100
-149,300
| -2% | -$10.8M |
2013 Q2
17 quarters
|
|
7
Novo Nordisk
NVO
$175B
| $691M | 0.81% |
28,722,600
+1,654,000
| +6% | +$37.4M |
2013 Q2
17 quarters
|
|
8
Bristol-Myers Squibb
BMY
$129B
| $691M | 0.81% |
10,846,600
-2,641,600
| -20% | -$154M |
2016 Q2
5 quarters
|
|
9
Domino's
DPZ
$10.3B
| $640M | 0.75% |
3,222,300
+161,400
| +5% | +$31.4M |
2013 Q2
17 quarters
|
|
10
VeriSign
VRSN
$27.8B
| $629M | 0.74% |
5,909,776
+864,300
| +17% | +$87M |
2013 Q2
17 quarters
|
|
11
PepsiCo
PEP
$185B
| $613M | 0.72% |
5,500,700
-142,000
| -3% | -$16.4M |
2013 Q2
17 quarters
|
|
|
12
Johnson & Johnson
JNJ
$670B
| $560M | 0.66% |
4,306,200
-1,826,000
| -30% | -$242M |
2015 Q3
8 quarters
|
|
13
Palo Alto Networks
PANW
$309B
| $533M | 0.63% |
22,187,400
+9,303,600
| +72% | +$212M |
2015 Q2
9 quarters
|
|
|
14
Medtronic
MDT
$124B
| $498M | 0.59% |
6,397,513
+5,963,513
| +1,374% | +$495M |
2017 Q2
1 quarter
|
|
15
Crown Castle
CCI
$37.6B
| $491M | 0.58% |
4,914,000
+38,497
| +0.8% | +$3.94M |
2015 Q1
10 quarters
|
|
16
Cboe Global Markets
CBOE
$34.8B
| $472M | 0.56% |
4,389,700
+19,704
| +0.5% | +$1.94M |
2013 Q2
17 quarters
|
|
17
Walmart Inc
WMT
$978B
| $472M | 0.56% |
18,129,000
+2,939,700
| +19% | +$77.1M |
2016 Q1
6 quarters
|
|
|
BCR
18
DELISTED
CR Bard Inc.
BCR
| $455M | 0.54% |
1,418,500
+122,900
| +9% | +$39.3M |
2013 Q2
17 quarters
|
|
19
Intuitive Surgical
ISRG
$157B
| $448M | 0.53% |
3,857,400
+1,093,500
| +40% | +$119M |
2013 Q2
17 quarters
|
|
20
Home Depot
HD
$328B
| $434M | 0.51% |
2,652,800
+773,400
| +41% | +$119M |
2016 Q2
5 quarters
|
|
|
21
Netflix
NFLX
$261B
| $385M | 0.45% |
21,236,000
+15,043,000
| +243% | +$262M |
2016 Q4
3 quarters
|
|
22
GSK
GSK
$99.1B
| $383M | 0.45% |
7,550,160
+79,760
| +1% | +$4.05M |
2013 Q2
17 quarters
|
|
23
Align Technology
ALGN
$10.7B
| $379M | 0.45% |
2,037,200
+449,519
| +28% | +$77M |
2013 Q2
17 quarters
|
|
24
Chubb
CB
$140B
| $371M | 0.44% |
2,600,761
+196,300
| +8% | +$28.4M |
2015 Q1
10 quarters
|
|
|
25
Mastercard
MA
$555B
| $353M | 0.42% |
2,500,100
-1,903,800
| -43% | -$252M |
2013 Q2
17 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2017 Portfolio in Review
As of Q3 2017, Renaissance Technologies held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Renaissance Technologies deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Renaissance Technologies's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Renaissance Technologies added most to Medtronic in Q3 2017, an estimated $495M increase.
- Renaissance Technologies's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Renaissance Technologies fully exited Amazon in Q3 2017, selling an estimated $290M.
- Renaissance Technologies's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Renaissance Technologies opened 418 new positions and closed 417 in Q3 2017.
- Renaissance Technologies's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.